首页 | 官方网站   微博 | 高级检索  
     

耐药乳腺癌免疫治疗的实验研究
引用本文:司玉玲,庞华,綦振家,乔丽葵,王英娟,李世俊.耐药乳腺癌免疫治疗的实验研究[J].天津医药,2012,40(4):359-362,420.
作者姓名:司玉玲  庞华  綦振家  乔丽葵  王英娟  李世俊
作者单位:1. 300140,天津市第四中心医院肿瘤血液科
2. 300140,天津市第四中心医院病理科
基金项目:天津市自然科学基金资助项目
摘    要:目的:探讨耐药乳腺癌抗原负载的树突细胞(DC)与细胞因子诱导的杀伤细胞(CIK)联合培养后对同种乳腺癌荷瘤小鼠的可能治疗机制.方法:分离健康人外周血获得单个核细胞,分别诱导为DC和CIK细胞,将人类乳腺癌耐药细胞株MCF-7/ADR细胞的冻融物抗原冲击DC(AP-DC),分别将DC与CIK细胞共培养(AP-DC+CIK组、DC+CIK组),将细胞经尾静脉注入裸鼠体内,观察不同组荷瘤标本中MDR1的表达、肿瘤细胞凋亡及凋亡相关蛋白Bax和Bcl-2的表达.结果:AP-DC+CIK组、DC+CIK组、CIK组及生理盐水组MDR1/β-actin比值分别为0.14、0.57、0.81及0.98.生理盐水组、CIK组、DC+CIK组和AP-DC+CIK组平均凋亡指数差异有统计学意义(P<0.001).各组Bcl-2及Bax蛋白表达的OD值差异有统计学意义(P<0.01),Bcl-2/Bax值AP-DC+CIK组<DC+CIK组<CIK组<生理盐水组.结论:经耐药乳腺癌抗原负载的DC与CIK共同作用后,诱导同种乳腺癌细胞凋亡强于单纯DC与CIK共同作用后及单独CIK的治疗效果.

关 键 词:树突细胞  杀伤细胞  淋巴因子激活  bcl-2相关X蛋白质  乳腺肿瘤  抗药性  肿瘤  疾病模型  动物

Pilot Study of Immunization Therapy on Drug-Resistance in Breast Cancer Bearing Mouse Model
SI Yuling , PANG Hua , QI Zhenjia , QIAO Likui , WANG Yingjuan , LI Shijun.Pilot Study of Immunization Therapy on Drug-Resistance in Breast Cancer Bearing Mouse Model[J].Tianjin Medical Journal,2012,40(4):359-362,420.
Authors:SI Yuling  PANG Hua  QI Zhenjia  QIAO Likui  WANG Yingjuan  LI Shijun
Affiliation:Department of Oncology and Hematology, Tianjin 4th Central Hospital, Tianjin 300140, China
Abstract:Objective:To explore the possible mechanisms of immunization therapy, cytokine-induced killer (CIK) cells co-cultured with dendritic cells (DC), on mutidrug-resistance breast cancer bearing mouse model. Methods:DC and CIK were cultured respectively from peripheral blood mononuclear cells (PBMC) derived from healthy individuals. MCF-7/ADR, a kind of breast cancer cell line with multidrug resistance, was prepared to obtain the antigen lyses. CIK was co-cultured with DC pulsed or unpulsed by the above antigen lyses (AP-DC+CIK and DC+CIK). The effector cells were injected into the tumor-bearing mice through tail intravenous. The expression of MDR1, tumor cell apoptosis and the expression of Bcl-2 and Bax were measured in 4 types of cells. Results:The ratio of MDR1 to β-actin was different in the above 4 types of cells, AP-DC+CIK group was 0.14, DC+CIK group was 0.57, CIK group was 0.81, and normal saline (NS) group was 0.98. The average apoptosis index was also significantly different in these 4 groups (P < 0.001). The values of optical density (OD) of protein Bcl-2 and Bax were different in 4 types of cells (P < 0.05). The value of Bcl-2/Bax was the lowest in AP-DC+CIK group, and then followed by DC+CIK group and CIK group. The value of Bcl-2/Bax was the highest in NS group. Conclusion:After CIK cells were co-cultured with DC loaded with multidrug resistance breast cancer antigen, the apoptosis of these breast cancer cells was higher than those of CIK cells co-cultured with DC and those of CIK.
Keywords:dendritic cells killer cells  lymphokine-activated bcl-2-associated X protein breast neoplasms drug resistance  neoplasm disease models  animal
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《天津医药》浏览原始摘要信息
点击此处可从《天津医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号